Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Lessons from the proteomic study of osteoarthritis.

Ruiz-Romero C, Fernández-Puente P, Calamia V, Blanco FJ.

Expert Rev Proteomics. 2015 Aug;12(4):433-43. doi: 10.1586/14789450.2015.1065182. Epub 2015 Jul 7.

PMID:
26152498
2.

Simple Case Treatment Planning: Diastema Closure.

Calamia V, Pantzis A.

Dent Clin North Am. 2015 Jul;59(3):655-64. doi: 10.1016/j.cden.2015.03.010. Review.

PMID:
26140972
3.

Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint.

Lourido L, Calamia V, Fernández-Puente P, Mateos J, Oreiro N, Blanco FJ, Ruiz-Romero C.

Proteomics Clin Appl. 2015 Apr 25. doi: 10.1002/prca.201400186. [Epub ahead of print]

PMID:
25914226
4.

The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases.

Ruiz-Romero C, Calamia V, Albar JP, Casal JI, Corrales FJ, Fernández-Puente P, Gil C, Mateos J, Vivanco F, Blanco FJ.

J Proteomics. 2015 Feb 14. pii: S1874-3919(15)00057-3. doi: 10.1016/j.jprot.2015.01.023. [Epub ahead of print] Review.

PMID:
25686859
5.

Quantitative proteomic profiling of human articular cartilage degradation in osteoarthritis.

Lourido L, Calamia V, Mateos J, Fernández-Puente P, Fernández-Tajes J, Blanco FJ, Ruiz-Romero C.

J Proteome Res. 2014 Dec 5;13(12):6096-106. doi: 10.1021/pr501024p. Epub 2014 Nov 21.

PMID:
25383958
6.

A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine.

Calamia V, Mateos J, Fernández-Puente P, Lourido L, Rocha B, Fernández-Costa C, Montell E, Vergés J, Ruiz-Romero C, Blanco FJ.

Sci Rep. 2014 Jun 10;4:5069. doi: 10.1038/srep05069.

7.

Secretome analysis of human mesenchymal stem cells undergoing chondrogenic differentiation.

Rocha B, Calamia V, Casas V, Carrascal M, Blanco FJ, Ruiz-Romero C.

J Proteome Res. 2014 Feb 7;13(2):1045-54. doi: 10.1021/pr401030n. Epub 2014 Jan 15.

PMID:
24400832
8.

Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties.

Calamia V, Lourido L, Fernández-Puente P, Mateos J, Rocha B, Montell E, Vergés J, Ruiz-Romero C, Blanco FJ.

Arthritis Res Ther. 2012 Oct 2;14(5):R202. doi: 10.1186/ar4040.

9.

Metabolic labeling of human bone marrow mesenchymal stem cells for the quantitative analysis of their chondrogenic differentiation.

Rocha B, Calamia V, Mateos J, Fernández-Puente P, Blanco FJ, Ruiz-Romero C.

J Proteome Res. 2012 Nov 2;11(11):5350-61. doi: 10.1021/pr300572r. Epub 2012 Oct 3.

PMID:
22989065
10.

Sequential depletion of human serum for the search of osteoarthritis biomarkers.

Fernández-Costa C, Calamia V, Fernández-Puente P, Capelo-Martínez JL, Ruiz-Romero C, Blanco FJ.

Proteome Sci. 2012 Sep 12;10(1):55. doi: 10.1186/1477-5956-10-55.

11.

Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF.

Mateos J, Lourido L, Fernández-Puente P, Calamia V, Fernández-López C, Oreiro N, Ruiz-Romero C, Blanco FJ.

J Proteomics. 2012 Jun 6;75(10):2869-78. doi: 10.1016/j.jprot.2011.12.042. Epub 2012 Jan 8.

PMID:
22245418
12.

Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes.

Calamia V, Fernández-Puente P, Mateos J, Lourido L, Rocha B, Montell E, Vergés J, Ruiz-Romero C, Blanco FJ.

Mol Cell Proteomics. 2012 Jun;11(6):M111.013417. doi: 10.1074/mcp.M111.013417. Epub 2011 Dec 27.

13.

Proteome analysis during chondrocyte differentiation in a new chondrogenesis model using human umbilical cord stroma mesenchymal stem cells.

De la Fuente A, Mateos J, Lesende-Rodríguez I, Calamia V, Fuentes-Boquete I, de Toro FJ, Arufe MC, Blanco FJ.

Mol Cell Proteomics. 2012 Feb;11(2):M111.010496. doi: 10.1074/mcp.M111.010496. Epub 2011 Oct 17.

14.

Hsp90β inhibition modulates nitric oxide production and nitric oxide-induced apoptosis in human chondrocytes.

Calamia V, de Andrés MC, Oreiro N, Ruiz-Romero C, Blanco FJ.

BMC Musculoskelet Disord. 2011 Oct 17;12:237. doi: 10.1186/1471-2474-12-237.

15.

Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-beta-mediated modulation of their intracellular and extracellular proteomes.

Calamia V, Rocha B, Mateos J, Fernández-Puente P, Ruiz-Romero C, Blanco FJ.

J Proteome Res. 2011 Aug 5;10(8):3701-11. doi: 10.1021/pr200331k. Epub 2011 Jul 5.

PMID:
21692455
16.

Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism.

Cabral MP, Soares NC, Aranda J, Parreira JR, Rumbo C, Poza M, Valle J, Calamia V, Lasa I, Bou G.

J Proteome Res. 2011 Aug 5;10(8):3399-417. doi: 10.1021/pr101299j. Epub 2011 Jun 17.

PMID:
21612302
17.

Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes.

Calamia V, Ruiz-Romero C, Rocha B, Fernández-Puente P, Mateos J, Montell E, Vergés J, Blanco FJ.

Arthritis Res Ther. 2010;12(4):R138. doi: 10.1186/ar3077. Epub 2010 Jul 13.

18.

Hypoxia conditions differentially modulate human normal and osteoarthritic chondrocyte proteomes.

Ruiz-Romero C, Calamia V, Rocha B, Mateos J, Fernández-Puente P, Blanco FJ.

J Proteome Res. 2010 Jun 4;9(6):3035-45. doi: 10.1021/pr901209s.

PMID:
20387907
19.

Strategies to optimize two-dimensional gel electrophoresis analysis of the human joint proteome.

Ruiz-Romero C, Calamia V, Carreira V, Mateos J, Fernández P, Blanco FJ.

Talanta. 2010 Feb 15;80(4):1552-60. doi: 10.1016/j.talanta.2009.05.022. Epub 2009 May 22.

PMID:
20082814
20.

Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance.

Ruiz-Romero C, Calamia V, Mateos J, Carreira V, Martínez-Gomariz M, Fernández M, Blanco FJ.

Mol Cell Proteomics. 2009 Jan;8(1):172-89. doi: 10.1074/mcp.M800292-MCP200. Epub 2008 Sep 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk